title: Toward the de novo design of antimicrobial peptides: Lack of correlation between peptide permeabilization of lipid vesicles and antimicrobial, cytolytic, or cytotoxic activity in living cells.
abstract: We previously performed a lipid vesicle-based, high-throughput screen on a 26-residue combinatorial peptide library that was designed de novo to yield membrane-permeabilizing peptides that fold into β-sheets. The most active and soluble library members that were identified permeabilized lipid vesicles detectably, but not with high potency. Nonetheless, they were broad-spectrum, membrane-permeabilizing antibiotics with minimum sterilizing activity at low µM concentrations. In an expansion of that work, we recently performed an iterative screen in which an active consensus sequence from that first-generation library was used as a template to design a second-generation library which was then screened against lipid vesicles at very high stringency. Compared to the consensus sequence from the first library, the most active second-generation peptides are highly potent, equilibrium pore-formers in synthetic lipid vesicles. Here, we use these first- and second-generation families of peptides to test the hypothesis that a large increase in potency in bacteria-like lipid vesicles will correlate with a large improvement in antimicrobial activity. The results do not support the hypothesis. Despite a 20-fold increase in potency against bacteria-like lipid vesicles, the second-generation peptides are only slightly more active against bacteria, and at the same time, are also more toxic against mammalian cells. The results suggest that a "pipeline" strategy toward the optimization of antimicrobial peptides could begin with a vesicle-based screen for identifying families with broad-spectrum activity, but will also need to include screening or optimization steps that are done under conditions that are more directly relevant to possible therapeutic applications.
authors.affiliation: Department of Biochemistry SL43, Tulane University School of Medicine, New Orleans, LA, 70112.
authors.forename: Jing
authors.initials: J
authors.lastname: He
authors.forename: Aram J
authors.initials: AJ
authors.lastname: Krauson
authors.forename: William C
authors.initials: WC
authors.lastname: Wimley
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D023181:Antimicrobial Cationic Peptides / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects; D016466:CHO Cells; D016923:Cell Death / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D006224:Cricetinae; D003412:Cricetulus; D015195:Drug Design; D008051:Lipid Bilayers / Q000737:chemistry*; D008826:Microbial Sensitivity Tests; D008969:Molecular Sequence Data; D010539:Permeability
chemical_list: D023181:Antimicrobial Cationic Peptides; D008051:Lipid Bilayers
keywords: antimicrobial peptide; high-throughput screening; vesicle leakage
references.citation: Biophys J. 2007 Feb 15;92(4):1271-83
references.pmid: 17114219
references.citation: Annu Rev Biophys Biomol Struct. 1999;28:319-65
references.pmid: 10410805
references.citation: Chem Phys Lipids. 2005 Apr;134(2):183-9
references.pmid: 15784236
references.citation: Protein Sci. 1994 Sep;3(9):1362-73
references.pmid: 7833799
references.citation: Biochemistry. 2007 Oct 30;46(43):12124-39
references.pmid: 17918962
references.citation: Immunobiology. 2006;211(4):315-22
references.pmid: 16697922
references.citation: Nat Biotechnol. 2006 Dec;24(12):1551-7
references.pmid: 17160061
references.citation: Infect Control Hosp Epidemiol. 2004 Oct;25(10):842-6
references.pmid: 15518026
references.citation: J Am Chem Soc. 2009 Jun 10;131(22):7609-17
references.pmid: 19445503
references.citation: ACS Chem Biol. 2010 Oct 15;5(10):905-17
references.pmid: 20698568
references.citation: FASEB J. 2010 Sep;24(9):3232-8
references.pmid: 20410445
references.citation: Proc Natl Acad Sci U S A. 2005 Jul 26;102(30):10511-5
references.pmid: 16020534
references.citation: J Am Chem Soc. 2012 Aug 1;134(30):12732-41
references.pmid: 22731650
references.citation: Peptides. 2001 Oct;22(10):1629-41
references.pmid: 11587791
references.citation: J Phys Chem B. 2012 Jan 12;116(1):179-88
references.pmid: 22091896
references.citation: Biochim Biophys Acta. 2010 Feb;1798(2):223-7
references.pmid: 19716800
references.citation: J Am Chem Soc. 2008 Jul 30;130(30):9849-58
references.pmid: 18611015
references.citation: Methods Enzymol. 1997;278:474-86
references.pmid: 9170328
references.citation: Biopolymers. 2002;66(4):236-48
references.pmid: 12491537
references.citation: ACS Chem Biol. 2013 Apr 19;8(4):823-31
references.pmid: 23394375
references.citation: Nat Struct Biol. 1996 Oct;3(10):842-8
references.pmid: 8836100
references.citation: Biophys J. 1995 Nov;69(5):1964-71
references.pmid: 8580339
references.citation: Biochim Biophys Acta. 2012 Jul;1818(7):1625-32
references.pmid: 22365969
references.citation: J Membr Biol. 2011 Jan;239(1-2):27-34
references.pmid: 21225255